Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.33 |
| ▸ | COPS5 | Q92905 | 1/20 | 0.33 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29806829 | 0.74 | ALDH1A1 (0.45) | ALDH1A1HSD17B10PRMT5 | |
| SCHEMBL6972765 | 0.74 | ALDH1A1 (0.45) | ALDH1A1HSD17B10PRMT5OPRM1OPRL1 | |
| SCHEMBL928489 | 0.74 | ALDH1A1 (0.45) | ALDH1A1HSD17B10PRMT5 | |
| SCHEMBL115602 | 0.74 | ALDH1A1 (0.45) | ALDH1A1HSD17B10PRMT5OPRM1OPRL1 | |
| SCHEMBL2093035 | 0.74 | ALDH1A1 (0.45) | ALDH1A1HSD17B10PRMT5 | |
| SCHEMBL5562354 | 0.74 | ALDH1A1 (0.45) | ALDH1A1HSD17B10PRMT5OPRM1OPRL1 | |
| SCHEMBL659126 | 0.74 | ALDH1A1 (0.45) | ALDH1A1HSD17B10PRMT5OPRM1OPRL1 | |
| SCHEMBL288616 | 0.74 | ALDH1A1 (0.45) | ALDH1A1HSD17B10PRMT5OPRM1OPRL1 | |
| SCHEMBL115601 | 0.74 | ALDH1A1 (0.45) | ALDH1A1HSD17B10OPRM1OPRL1 | |
| SCHEMBL30081471 | 0.74 | ALDH1A1 (0.45) | ALDH1A1HSD17B10OPRM1OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118389576-B | Autophagy related protein ZmATG c and application of encoding gene thereof in regulation of heat resistance of plants | 西北农林科技大学 | 2026-05-19 | — | — | CN | disclosed |
| CN-118389576-A | Autophagy related protein ZmATG c and application of encoding gene thereof in regulation of heat resistance of plants | 西北农林科技大学 | 2024-07-26 | — | — | CN | disclosed |
| US-11498930-B2 | Pyrimidine-fused cyclic compound, preparation method therefor and application thereof | Blueray Therapeutics (Shanghai) Co., Ltd (CN) | 2022-11-15 | — | — | US | disclosed |
| CN-111057074-B | Inhibitors of influenza virus replication and uses thereof | 广东东阳光药业有限公司 | 2022-04-29 | — | — | CN | disclosed |
| US-20210053989-A1 | PYRIMIDINE-FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | SHANGHAI BLUERAY BIOPHARMA CO., LTD. (CN) | 2021-02-25 | — | — | US | disclosed |
| CN-111057074-A | Inhibitors of influenza virus replication and uses thereof | 广东东阳光药业有限公司 | 2020-04-24 | — | — | CN | disclosed |
| EP-0451983-A2 | Power transmission belt | MITSUBOSHI BELTING LTD. (JP) | 1991-10-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11498930-B2 | Pyrimidine-fused cyclic compound, preparation method therefor and application thereof | PTPN11, PPM1F, PTPRF | ALDH1A1 3190/4885HSD17B10 3100/4885PSMD14 4114/4885 |
| US-20210053989-A1 | PYRIMIDINE-FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | PTPN11, PPM1F, PTPRF | ALDH1A1 3190/4885HSD17B10 3100/4885PSMD14 4114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.